| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |